+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

Anti-CD28 Antibody - Pipeline Insight, 2024 - Product Thumbnail Image

Anti-CD28 Antibody - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Anti-CD279 (PD-1) Antibody - Pipeline Insight, 2024 - Product Thumbnail Image

Anti-CD279 (PD-1) Antibody - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
Anti-CD274 (PD-L1) Antibody - Pipeline Insight, 2024 - Product Thumbnail Image

Anti-CD274 (PD-L1) Antibody - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
Anti-CD19 Antibody - Pipeline Insight, 2024 - Product Thumbnail Image

Anti-CD19 Antibody - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Anti-CD152 Antibody - Pipeline Insight, 2024 - Product Thumbnail Image

Anti-CD152 Antibody - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Anti GM-CSF Antibody - Pipeline Insight, 2024 - Product Thumbnail Image

Anti GM-CSF Antibody - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Hepcidin Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

Hepcidin Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Estrogen Receptor Beta Partial Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

Estrogen Receptor Beta Partial Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
CD3 antigen inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

CD3 antigen inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Proteasome inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Proteasome inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Sphingosine 1 phosphate receptor modulators - Pipeline Insight, 2024 - Product Thumbnail Image

Sphingosine 1 phosphate receptor modulators - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Oncolytic Virus Cancer Therapy - Pipeline Insight, 2024 - Product Thumbnail Image

Oncolytic Virus Cancer Therapy - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 280 Pages
  • Global
From
From
From
From
From
From
From
From
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more